chenodeoxycholic acid has been researched along with Diabetes Mellitus in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auwerx, J; Gioiello, A; Macchiarulo, A; Natalini, B; Pastorini, E; Pellicciari, R; Pruzanski, M; Roda, A; Rosatelli, E; Sardella, R; Schoonjans, K; Thomas, C | 1 |
Akhlaghi, F; Chen, Y; Deng, R; Ghareeb, M; Guo, L; Nadolny, C; Shiffka, S; Valanejad, L; Verma, R; You, S | 1 |
Fonseca, VA; Staels, B | 1 |
Danzinger, RG; Kurtas, TK; Torchia, MG | 1 |
Klapdor, R | 1 |
2 review(s) available for chenodeoxycholic acid and Diabetes Mellitus
Article | Year |
---|---|
Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol, HDL; Cholesterol, LDL; Cholic Acid; Diabetes Mellitus; Digestion; Homeostasis; Humans; Intestinal Absorption; Intestines; Liver; Obesity | 2009 |
[Gastrointestinal hormones: present status].
Topics: Adenoma, Islet Cell; Chenodeoxycholic Acid; Cholecystokinin; Cholelithiasis; Dehydration; Diabetes Mellitus; Duodenal Ulcer; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Humans; Motilin; Pancreatic Neoplasms; Secretin; Syndrome; Vasoactive Intestinal Peptide; Zollinger-Ellison Syndrome | 1979 |
1 trial(s) available for chenodeoxycholic acid and Diabetes Mellitus
Article | Year |
---|---|
Low-dose chenodeoxycholic acid for gallstone dissolution: a randomized trial in poor operative risk patients.
Topics: Aged; Chenodeoxycholic Acid; Cholelithiasis; Clinical Trials as Topic; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Obesity; Placebos; Research Design; Solubility; Time Factors | 1980 |
2 other study(ies) available for chenodeoxycholic acid and Diabetes Mellitus
Article | Year |
---|---|
Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity.
Topics: Animals; Chlorocebus aethiops; CHO Cells; Cholic Acids; COS Cells; Cricetinae; Cricetulus; Diabetes Mellitus; Humans; Obesity; Rats; Receptors, G-Protein-Coupled; Stereoisomerism | 2009 |
Dysregulation of Δ
Topics: Adult; Aged; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Case-Control Studies; Chenodeoxycholic Acid; Cholesterol 7-alpha-Hydroxylase; Diabetes Mellitus; Female; Hep G2 Cells; Homeostasis; Humans; Liver; Male; Mice; Middle Aged; Oxidoreductases; PPAR alpha; Promoter Regions, Genetic; Signal Transduction | 2018 |